MENU
+Compare
SNGX
Stock ticker: NASDAQ
AS OF
Feb 4, 03:41 PM (EDT)
Price
$1.17
Change
-$0.07 (-5.69%)
Capitalization
12.41M

SNGX Soligenix Inc. Forecast, Technical & Fundamental Analysis

Soligenix Inc is a late-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
SNGX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SNGX with price predictions
Feb 03, 2026

SNGX in upward trend: price expected to rise as it breaks its lower Bollinger Band on January 30, 2026

SNGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where SNGX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNGX advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SNGX as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SNGX turned negative on January 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

SNGX moved below its 50-day moving average on January 08, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SNGX entered a downward trend on February 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.633) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.843).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SNGX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNGX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SNGX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of biodefense vaccines and oral therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEHR27.191.13
+4.34%
Aehr Test Systems
GPOR200.916.40
+3.29%
Gulfport Energy Corp
KVUE17.590.21
+1.21%
Kenvue
HIND2.07-0.13
-5.91%
Vyome Holdings Inc
AREN3.43-0.47
-12.05%
Arena Group Holdings (The)

SNGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been loosely correlated with THAR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNGX jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
N/A
THAR - SNGX
46%
Loosely correlated
-2.01%
QURE - SNGX
36%
Loosely correlated
+12.55%
LGVN - SNGX
34%
Loosely correlated
+3.08%
DCOY - SNGX
32%
Poorly correlated
-5.26%
GRDX - SNGX
31%
Poorly correlated
+9.90%
More